Anti-CD40 Anticorps (A323378)

Dacetuzumab Biosimilar - Anti-CD40 Antibody - Low endotoxin, Azide free

Recombinant humanized monoclonal antibody to CD40.

ELISA, FACS, Functional Assay, In Vivo

Human

Humanized

Monoclonal

IgG1

kappa

Unconjugated

Protein A affinity chromatography.

Reconstitution dependent.

This antibody has a predicted MW of 145 kDa.

Lyophilized

Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!

Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

AI326936, B cell associated molecule , B cell associated molecule CD40, B cell surface antigen CD40 , B cell-associated molecule, B-cell surface antigen CD40, Bp50, CD 40 , CD40 antigen , CD40 antigen (TNF receptor superfamily member 5), CD40 molecule , CD40 molecule TNF receptor superfamily member 5, CD40 molecule, TNF receptor superfamily member 5, CD40 protein , CD40 type II isoform , CD40L receptor , CDw40, GP39 , HIGM1, IGM , IMD3, MGC9013, Nerve growth factor receptor related B lymphocyte activation molecule , NFRSF5 , OTTHUMP00000031699, OTTHUMP00000031700 , p50, T BAM , T-BAM, TBAM, TNF receptor superfamily member 5, TNFRSF5, TNR5_HUMAN, TRAP, Tumor necrosis factor receptor superfamily , member 5, Tumor necrosis factor receptor superfamily member 5, Tumor necrosis factor receptor superfamily member 5 precursor , Tumor necrosis factor receptor superfamily, member 5, isoform CRA_a